Request Discount

Therapeutic BCG Vaccines Market (Type - Immune BCG, and Therapy BCG; Demographics - Pediatrics, and Adults; End User - Hospitals, Clinics, and Other End Users): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025

  • Published : June, 2019

  • Rep Id : HC0555

  • Category : Healthcare & Medical Devices

  • Status : Published

This report provides exclusive insights into the COVID-19 impact on the Therapeutic BCG Vaccines Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Therapeutic BCG Vaccines Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Therapeutic BCG Vaccines Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.

A recent report published by Infinium Global Research on therapeutic BCG vaccines market provides in-depth analysis of segments and sub-segments in the global as well as regional therapeutic BCG vaccines market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional therapeutic BCG vaccines market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global therapeutic BCG vaccines market. According to the report, the global therapeutic BCG vaccines market is projected to grow at a CAGR of 4.5% over the forecast period of 2019-2025.


Global Therapeutic BCG Vaccines Market

 

Market Insight

Bacillus Calmette–Guérin (BCG) is a vaccine used for the prevention of tuberculosis. One-fourth of the World’s population is infected with tuberculosis. Tuberculosis is one of the top 10 causes of death worldwide. BCG is one of the successful immunotherapies. BCG vaccine is 70-80 percent effective against various forms of tuberculosis. BCG is used in several countries with a high prevalence of TB to prevent childhood tuberculous, meningitis and military disease.

 

The rising prevalence of tuberculosis drives the growth of the therapeutic BCG vaccines market. The increasing government initiative to create awareness programs for immunization contributes to the growth of therapeutic BCG vaccines market. In addition, growing technological advancement in vaccines boosts the growth of therapeutic BCG vaccines market. On the other hand, the BCG vaccine has some side effects such as swollen lymph nodes, frequent urination, and vomiting which restraints the growth of therapeutic BCG vaccines market. However, increasing demand from various underdeveloped and developing regions for BCG vaccines creates opportunities for several BCG vaccine manufacturers to expand their business.

 

Geographically, the Asia-Pacific region holds the largest share in the therapeutic BCG vaccines market. The high prevalence of tuberculosis in countries such as China, India, Indonesia, and several other Asian countries primarily contributes to the growth of the therapeutic BCG vaccines market in the Asia Pacific region. Furthermore, government initiatives taken in Asian countries for the prevention of tuberculosis stimulates the growth of therapeutic BCG vaccines market in the Asia-Pacific region. For instance, India, in 1929, became a member of the International Union Against Tuberculosis (IUAT). Since the government of India is taking initiative for BCG vaccination. However, North America is projected to grow at a sluggish growth owing to the low prevalence of tuberculosis in this region. While, the other regions of the world such as the African region, low income countries and lower-middle income countries are highly affected with tuberculosis that is expected to project a high CAGR over the forecast period.

 

Segment Covered

The report on global therapeutic BCG vaccines market covers segments such as type, demographics, and end user. On the basis of type, the sub-markets include immune BCG, and therapy BCG. On the basis of demographics, the sub-markets include pediatrics, and adults. On the basis of end user, the sub-markets include hospitals, clinics, and other end users.

 

Companies Profiled:

The report provides profiles of the companies in the market such as Sanofi Pasteur, Merck & Co., Inc., Serum Institute of India Private Limited, InterVax Ltd., Green Signal Bio Pharma Pvt Ltd, Statens Serum Institut, China National Biotec Group, Japan BCG Laboratory, and Other companies.

 

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of therapeutic BCG vaccines market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.


Other Reports in This Category
24 hour delivery through email
9923950043 Monday to Frieday 9am-7pm
looking for discount